FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in California, United States

Biotech startups in California, United States

Updated 16 Nov 2026

Reset
Biotech startups in California, United States
One-time CSV
  • 1,577 funded companies, 1,361 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~california-united-states.csv1,577 rows × 18 columns
CompanyCityLast roundAmountDate
Multiply LabsSan FranciscoSeries B$75.0M2026-10-06
CraifIrvineSeries D$24.4M2026-08-18
Chai DiscoverySan FranciscoSeries C$400.0M2026-07-14
Prolific MachinesEmeryvilleSeries B$50.0M2026-10-14
Profluent BioEmeryvilleSeries B$106.0M2025-11-19
BigHat BiosciencesSan MateoSeries C$75.0M2026-09-24
TwoStep TherapeuticsPalo AltoSeries A$62.5M2026-09-09
BillionToOneMenlo ParkSeries D$130.0M2024-06-21

8 rows of the CSV in 5 of its 18 columns.

1,577
Startups
$77.4B
Total raised
228
Funded in the last 12 months
$8.1B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 1,577
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego Series A $6.0M 2026-11-03 $35.0M Liquid 2 Ventures, Global Brain Corporation, BlueYard Capital +2 11 to 50 2022
Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence San Francisco Series A $12.0M 2026-10-15 $22.9M Y Combinator, Khosla Ventures, TenOneTen Ventures +2 11 to 50 2018
Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
Welltory Welltory produces AI-powered wellness apps for digital health tracking. Artificial intelligence Redwood City Seed $2.0M 2026-10-08 $16.3M Goodwater Capital, JOINT JOURNEY, CABRA VC 51 to 100 2016
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
BigHat Biosciences BigHat Biosciences develops antibody and protein therapeutics using machine learning and automated experimentation. Artificial intelligence San Mateo Series C $75.0M 2026-09-24 $174.3M Andreessen Horowitz, Gaingels, 8VC +2 51 to 100 2019
ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Palo Alto Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence San Francisco Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
PGxAI PGxAI provides a clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence. Artificial intelligence Palo Alto Seed $3.0M 2026-09-14 $5.0M ATEM Capital Fund LP 11 to 50 2023
TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
N-Power Medicine N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. Artificial intelligence Redwood City Series B $32.0M 2026-09-01 $104.0M Merck Global Health Innovation Fund 101 to 250 2021
Craif Craif develops a cancer diagnosis algorithm using microRNA data and machine learning. Artificial intelligence Irvine Series D $24.4M 2026-08-18 $68.7M Global Brain Corporation, VentureOut, ANRI +1 51 to 100 2018
Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
Integrated Biosciences Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. Artificial intelligence Redwood City Series A $68.4M 2026-08-05 $85.6M Root Ventures, Reinforced Ventures, Mission BioCapital +2 11 to 50 2022
Rybodyn Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. Biotech San Diego Seed $1.3M 2026-07-23 $15.3M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2022
Transcripta Bio Transcripta Bio develops drugs at an accelerated pace with reduced risk. Biotech Palo Alto Series A $24.0M 2026-07-22 $34.4M BlueYard Capital, Jazz Venture Partners 11 to 50 2020
Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech South San Francisco Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
Cellanome Cellanome uses synthetic biology and informatics methods to analyze multi-omics data. Biotech Redwood City Series C $75.9M 2026-06-18 $289.6M Premji Invest, Synetro Group 51 to 100 2020
Kopra Bio Kopra Bio develops viral immunotherapy treatments to cure cancer. Biotech San Francisco Seed $9.1M 2026-06-16 $9.7M Y Combinator, Pioneer Fund 1 to 10 2024
Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego Series E $277.0M 2026-06-09 $678.0M RA Capital Management, Fidelity, Wellington Management +2 251 to 500 2017
ParcelBio ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. Biotech San Francisco Seed $13.0M 2026-05-07 $13.5M Y Combinator, Alumni Ventures, Pioneer Fund +2 1 to 10 2024
LTZ Therapeutics LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. Biotech San Francisco Series B $38.0M 2026-05-06 $125.0M Qiming Venture Partners, Shunwei Capital, K2VC +1 11 to 50 2022
Fermeate Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. Biotech San Francisco Seed $2.5M 2026-04-27 $2.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech San Francisco Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
TippingPoint Biosciences TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. Biotech San Francisco Seed $4.5M 2026-03-31 $4.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
Numerion Labs Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. Artificial intelligence San Francisco Series D $19.8M 2026-03-19 $241.4M Y Combinator, Khosla Ventures, Creative Destruction Lab +1 11 to 50 2012
Condor Software Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time. Biotech San Diego Series A $24.0M 2026-03-18 $29.5M Plug and Play, MassChallenge, Pareto Holdings +1 11 to 50 2020

Table 1. Biotech startups in California, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,577.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence San Francisco Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Element Biosciences Unicorn Element Biosciences develops genomic sequencing and multiomics technologies for drug discovery and diagnostic applications. Biotech San Diego Series E $277.0M 2026-06-09 $678.0M RA Capital Management, Fidelity, Wellington Management +2 251 to 500 2017
3 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
4 Angitia Biopharmaceuticals Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases. Biotech Westlake Village Series D $130.0M 2026-02-05 $406.0M Legend Capital, OrbiMed, Oriza Holdings +1 51 to 100 2018
5 Aspen Neuroscience Aspen Neuroscience is a biotechnology company that develops personalized cell therapies and autologous regenerative medicine. Biotech San Diego Series C $115.0M 2025-11-20 $387.0M Google Ventures, OrbiMed, EDBI +2 101 to 250 2018
6 Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech San Francisco Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
7 Profluent Bio Profluent Bio designs new proteins and gene-editing tools using AI for medicine, agriculture, and science. Artificial intelligence Emeryville Series B $106.0M 2025-11-19 $150.0M Insight Partners, Spark Capital, AIX Ventures +1 11 to 50 2022
8 Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
9 Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech San Francisco Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
10 Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012

Table 2. Biotech startups in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 49 3% 9 Probably Genetic, Multiply Labs, Kopra Bio
2 SOSV Venture capital firm Princeton, United States 16 1% 6 Prolific Machines, Farm Minerals, Rybodyn
3 Khosla Ventures Venture capital firm Menlo Park, United States 14 1% 5 Probably Genetic, Moonwalk Biosciences, Prellis Biologics
4 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 13 1% 6 Prolific Machines, Farm Minerals, Rybodyn
5 RA Capital Management Startup incubator Boston, United States 13 1% 1 Element Biosciences
6 Plug and Play Startup accelerator Sunnyvale, United States 13 1% 4 ImpriMed, Prellis Biologics, WittGen Biotechnologies
7 National Science Foundation Entrepreneurship program Alexandria, United States 12 1% 2 BreezeBio, Culture Biosciences
8 Alumni Ventures Angel group Manchester, United States 12 1% 1 ParcelBio
9 OrbiMed Private equity firm New York, United States 12 1% 5 Terremoto Biosciences, Angitia Biopharmaceuticals, Mirador Therapeutics
10 Andreessen Horowitz Venture capital firm Menlo Park, United States 10 1% 1 BigHat Biosciences
11 Pioneer Fund Startup accelerator Toronto, Canada 10 1% 3 Kopra Bio, ParcelBio, Angstrom AI
12 Bristol-Myers Squibb Venture capital firm New York, United States 9 1% 1 BigHat Biosciences
13 Alexandria Venture Investments Venture capital firm Pasadena, United States 9 1% 3 TwoStep Therapeutics, Lycia Therapeutics, Aspen Neuroscience
14 ARCH Venture Partners Venture capital firm Chicago, United States 9 1% 2 Moonwalk Biosciences, Mirador Therapeutics
15 500 Global Startup accelerator Palo Alto, United States 8 1%

Table 3. Biotech startups in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 1,257 80% $67.7B
Software 331 21% $14.1B
Artificial intelligence 224 14% $9.9B
Hardware 57 4% $3.0B
Fintech 16 1% $959.5M
Energy 15 1% $678.2M
Cybersecurity 14 1% $571.2M
Commerce 6 0% $128.3M
Education 6 0% $3.3M

Table 4. Biotech startups in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 160 10% $500K
Seed 561 36% $2.0M
Series A 366 23% $20.0M
Series B 236 15% $33.5M
Series C 143 9% $35.0M
Series D+ 111 7% $43.7M

Table 5. Biotech startups in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 396 25%
San Diego 231 15%
Palo Alto 87 6%
South San Francisco 69 4%
Berkeley 57 4%
Los Angeles 56 4%
Menlo Park 47 3%
Mountain View 43 3%
Redwood City 39 2%
Irvine 33 2%
San Jose 28 2%
San Carlos 28 2%

Table 6. Biotech startups in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 0% $6.0M
October 2026 24 11% $814.0M
September 2026 22 10% $823.1M
August 2026 15 7% $477.2M
July 2026 17 7% $610.4M
June 2026 20 9% $1.0B
May 2026 19 8% $381.5M
April 2026 11 5% $385.1M
March 2026 24 11% $389.4M
February 2026 12 5% $414.9M
January 2026 34 15% $1.5B
December 2025 22 10% $886.5M
November 2025 7 3% $397.0M

Table 7. Biotech startups in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 199 13% $6.8B
2025 176 11% $6.3B
2024 158 10% $5.7B
2023 117 7% $2.6B
2022 127 8% $3.4B
2021 143 9% $7.8B

Table 8. Biotech startups in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 254 16%
2020 to 2022 259 17%
2015 to 2019 482 31%
2010 to 2014 261 17%
Before 2010 303 19%

Table 9. Biotech startups in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 652 42%
11 to 50 639 42%
51 to 100 139 9%
101 to 250 62 4%
251 to 500 15 1%
501 to 1,000 13 1%
1,001 to 5,000 5 0%
5,001 to 10,000 4 0%
10,001 or more 7 0%

Table 10. Biotech startups in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in California, United States are on the list?
1,577, in the file dated 16 November 2026. 228 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 1,577 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in California, United States: 1,577 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in California, United States by funding stage

Other sectors in California

Biotech startups elsewhere

Cite: FundingWatcher, 1,577 funded biotech companies in California, United States, 16 November 2026. https://fundingwatcher.com/startups/biotech/california-united-states/